Repare Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Repare Therapeutics

09/08/2023 22:04

* Repare Therapeutics Inc  RPTX.OQ  reported a quarterly
adjusted
loss of 28 cents​​ per share for the quarter ended in June. The
mean expectation of eight analysts for the quarter was for a
loss of 78 cents per share.
    * Revenue rose 4,354.9% to $30.25 million from a year ago;
analysts expected $7.68 million. 
    * Repare Therapeutics Inc's reported EPS for the quarter was
a
loss of 28 cents​.
    * The mean earnings estimate of analysts had risen by
about 2.2%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Repare Therapeutics Inc shares had fallen by 22.1% this
quarter and lost 44.0% so far this year.
    * The company reported a quarterly loss of $11.95 million.
    * Wall Street's median 12-month price target for Repare
Therapeutics Inc is $27.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 09:04 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.78          -0.28          Beat
 Mar. 31 2023      -0.81          -0.83          Missed
 Dec. 31 2022      -0.72          -0.75          Missed
 Sep. 30 2022      -0.89          1.71           Beat